| abstract |
The present invention relates to compounds of formula (I) or their stereoisomer, tautomer or pharmaceutically acceptable salt, where all variables are defined in the description of the invention. These compounds are selective factor XIa inhibitors or dual-action inhibitors of factor XIa and plasma kallikrein and can be used to treat thromboembolic and / or inflammatory disorders. |